Clinical Trials Browser

Genital Diseases, Carcinoma, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Male Urogenital Diseases

NCT05834270 2023-04-28

Single Dose Versus Double Dose Tamsulosin in Management of Moderate and Severe LUTS Due to BPH

Phase NA Completed

60 enrolled

Genitourinary

Prostatic Diseases, Prostatic Hyperplasia, Prostatic Neoplasms

NCT05399940 2022-06-01

The Relationship Between Serum PSA Levels and WBC, Delta Neutrophil Index (DNI) and Other Hematological Parameters

Completed

250 enrolled

Genitourinary

Prostatic Diseases, Prostatic Neoplasms

NCT00210249 2022-02-04

PHRC2003

Completed

364 enrolled 4 charts

GenitourinaryGynecologicLymphoid

Urinary Bladder Diseases, Digestive System Diseases, Lung Diseases, Lymphoma, Neoplasms, Ovarian Diseases, Prostatic Diseases

NCT03938376 2021-04-01

Micro-Ultrasound/Magnetic Resonance Imaging 001

Completed

100 enrolled

Genitourinary

Prostatic Diseases

NCT03847753 2020-05-22

COMO-GMC

Completed

5,940,299 enrolled

Classical hematologyGenitourinaryHead & Neck

Acquired Immunodeficiency Syndrome, Anemia, Feeding and Eating Disorders, Atrial Fibrillation, Behavior, Mental Disorders, Connective Tissue Diseases, Diabetes Mellitus, Epilepsy, Gout, Hearing Disorders, Heart Failure, Hypersensitivity, Hypertension, Intellectual Disability, Migraine Disorders, Multiple Sclerosis, Neoplasms, Osteoporosis, Pain, Parkinson Disease, Prostatic Diseases, Schizophrenia, Somatoform Disorders, Thyroid Diseases, Vision Disorders, Inflammatory Bowel Diseases, Myocardial Ischemia, Mood Disorders, Substance-Related Disorders, Stroke, Dyslipidemias, Renal Insufficiency, Chronic

NCT01310894 2019-07-11

PCM301

Phase 3 Completed

413 enrolled

Genitourinary

Carcinoma, Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Male Urogenital Diseases

NCT00707356 2016-04-19

Study of WST11 in Patients With Localized Prostate Cancer

Phase 2 Completed

42 enrolled

Genitourinary

Genital Diseases, Carcinoma, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Male Urogenital Diseases

NCT01307852 2016-04-06

In Vivo Dosimetry During Prostate Cancer Radiotherapy

Phase 1 Completed

7 enrolled

Genitourinary

Prostatic Diseases

NCT00975429 2015-04-28

Study Using WST11 in Patients With Localized Prostate Cancer

Phase 2 Completed

86 enrolled

Genitourinary

Carcinoma, Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Male Urogenital Diseases

Clinical Trials

High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical Prostatectomy

Test Semiquantitative Prostate Specific Antigen (PSA)

MAPROSTATE

Safety and Tolerability Study Using WST11 In Patients With Localized Prostate Cancer

Single Dose Versus Double Dose Tamsulosin in Management of Moderate and Severe LUTS Due to BPH

The Relationship Between Serum PSA Levels and WBC, Delta Neutrophil Index (DNI) and Other Hematological Parameters

PHRC2003

Micro-Ultrasound/Magnetic Resonance Imaging 001

COMO-GMC

PCM301

Study of WST11 in Patients With Localized Prostate Cancer

In Vivo Dosimetry During Prostate Cancer Radiotherapy

Study Using WST11 in Patients With Localized Prostate Cancer